Congress Takes Action to Expand Cannabis Research with Medical Cannabis Act

The House Judiciary Committee took action on H.R.5634: The Medical Cannabis Act of 2018. The Medical Cannabis Act will increase the number of suppliers that can provide cannabis to researchers, including those engaged in commercial drug development. Within a year of the bill’s enactment, Attorney General Jeff Sessions will be required to register at least two (2) cannabis suppliers, and at least three (3) every year thereafter. The bill also permits the Department of Veterans Affairs to provide veteran’s with information about federally approved cannabis clinical trials, and to help the veteran’s complete the required forms.